Nonvirally engineered porcine adipose tissue-derived stem cells: Use in posterior spinal fusion

Stem Cells

Volumn 26, Issue 4, 2008, Pages 1056-1064

  Sheyn, Dima ^a   Pelled, Gadi ^a   Zilberman, Yoram ^a   Talasazan, Farahnaz ^b   Frank, Jonathan M ^b   Gazit, Dan ^a,b   Gazit, Zulma ^a,b,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adipose tissue derived stem cells; Bone morphogenetic protein; Genetic engineering; Nonviral gene delivery; Posterior spinal fusion

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; GREEN FLUORESCENT PROTEIN;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; GENETIC ENGINEERING; GENETIC TRANSFECTION; HISTOLOGY; LUMBAR SPINE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSSIFICATION; PROTEIN SECRETION; REPORTER GENE; SPINE FUSION; STEM CELL; SWINE; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; METHODOLOGY; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALIA; MUS; SUS;

ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; FEMALE; MICE; MICE, INBRED NOD; MICE, SCID; SPINAL FUSION; STEM CELL TRANSPLANTATION; STEM CELLS; SWINE; TISSUE ENGINEERING;

EID: 49249127420     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0858     Document Type: Article

References (38)

1. Kraemer J. Natural course and prognosis of intervertebral disc diseases. International Society for the Study of the Lumbar Spine Seattle, Washington, June 1994. Spine 1995;20:635-639.
2. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine 1995;20:1307-1314.
3. Nishida K, Kang JD, Gilbertson LG et al. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 1999;24:2419-2425.
4. Frick SL, Hanley EN Jr, Meyer RA Jr et al. Lumbar intervertebral disc transfer. A canine study. Spine 1994;19:1826-1834; discussion 1834-1825.
5. Bao QB, McCullen GM, Higham PA et al. The artificial disc: Theory, design and materials. Biomaterials 1996;17:1157-1167.
6. Aslan H, Zilberman Y, Arbeli V et al. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 2006;12:877-889.
7. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100:1249-1260.
8. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
9. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-228.
10. Turgeman G, Pittman DD, Müller R et al. Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy. J Gene Med 2001;3:240-251.
11. Quarto R, Mastrogiacomo M, Cancedda R et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-386.
12. Dragoo JL, Choi JY, Lieberman JR et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 2003;21:622-629.
13. Dragoo JL, Lieberman JR, Lee RS et al. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg 2005;115:1665-1673.
14. Peterson B, Zhang J, Iglesias R et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 2005;11:120-129.
15. Lendeckel S, Jodicke A, Christophis P et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J Craniomaxillofac Surg 2004;32:370-373.
16. Schäffler A, Buchler C. Concise review: Adipose tissue-derived stromal cells - Basic and clinical implications for novel cell-based therapies. STEM CELLS 2007;25:818-827.
17. Gazit D, Turgeman G, Kelley P et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy. J Gene Med 1999;1:121-133.
18. Moutsatsos IK, Turgeman G, Zhou S et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 2001;3:449-461.
19. Turgeman G, Aslan H, Gazit Z et al. Cell mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 2002;4:390-394.
20. Hasharoni A, Zilberman Y, Turgeman G et al. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J Neurosurg Spine 2005;3:47-52.
21. Kimelman N, Pelled G, Gazit Z et al. Applications of gene therapy and adult stem cells in bone bioengineering. Regen Med 2006;1:549-561.
22. Kimelman N, Pelled G, Helm GA et al. Review: Gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng 2007;13:1135-1150.
23. Li JZ, LI H, Sasaki T et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 2003;10:1735-1743.
24. Cheng H, Jiang W, Phillips FM et al. Osteogenic activity of the 14 types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A:1544-1552.
25. Zaragosi LE, Billon N, Ailhaud G et al. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. STEM CELLS 2007;25:790-797.
26. Hamm A, Krott N, Breibach I et al. Efficient transfection method for primary cells. Tissue Eng 2002;8:235-245.
27. Aslan H, Zilberman Y, Kandel L et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. STEM CELLS 2006;24:1728-1737.
28. Calve S, Dennis RG, Kosnik PE 2nd et al. Engineering of functional tendon. Tissue Eng 2004:755-761.
29. Müller R, Ruegsegger P. Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud Health Technol Inform 1997;40:61-79.
30. Hildebrand T, Laib A, Müller R et al. Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999;14:1167-1174.
31. Müller R, Van Campenhout H, Van Damme B et al. Morphometric analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed tomography. Bone 1998;23:59-66.
32. Müller R, Hildebrand T, Ruegsegger P. Non-invasive bone biopsy: A new method to analyse and display the three-dimensional structure of trabecular bone. Phys Med Biol 1994;39:145-164.
33. Bright C, Park YS, Sieber AN et al. In vivo evaluation of plasmid DNA encoding OP-1 protein for spine fusion. Spine 2006;31:2163-2172.
34. Peterson B, Iglesias R, Zhang J et al. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: Beyond conventional autologous bone grafting. Spine 2005;30:283-289; discussion 289-290.
35. Hidaka C, Goshi K, Rawlins B et al. Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine 2003;28:2049-2057.
36. Dumont RJ, Dayoub H, Li JZ et al. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 2002;51:1239-1244; discussion 1244-1235.
37. Drespe IH, Polzhofer GK, Turner AS et al. Animal models for spinal fusion. Spine J 2005;5(suppl):209S-216S.
38. Qu CQ, Zhang GH, Zhang LJ et al. Osteogenic and adipogenic potential of porcine adipose mesenchymal stem cells. In Vitro Cell Dev Biol Anim 2007;43:95-100.